WASHINGTON - Low blood sugar, also known as hypoglycemia, could turn out to be a serious health threat for patients with chronic kidney disease (CKD), according to a study.
WASHINGTON - A research team, including an Indian-origin boffin, has shed light on why people with diabetes have high blood glucose levels.
Seroquel is an antipsychotic drug manufactured and marketed by London based drug maker AstraZeneca Plc. It has diabetes related side effects. In clinical trials of the drug, patients have been diagnosed with diabetes mellitus, hyperglycemia and weight gain.
MIAMI - The military chief of Colombia’s largest rebel group is on the verge of death at a secret jungle hideout as he is unable to receive treatment for his chronic diabetes, EFE reported Friday.
Liraglutide the Novo Nordisk’s experimental type 2 diabetes drug is proved to control the blood sugar better. In a 26 week long head to head trial this Danish company finds that the patients given the liraglutide once a day have received a reduction of 1.1 percent in HCA1c levels, a key ingredient in blood sugar. Thus the drug works a step ahead of the other drug Byetta that has recorded less than 0.8% reduction in the blood sugar. Nearly 55% of the liraglutide patients reached the ADA target compared with close to 45 percent on Byetta, known chemically as exenatide. The company Novo Nordisk is looking forward to European and American approval next month.
The recent study by the Sydney based George Institute for International Health, finds out that by lowering the blood glucose level, patients can reduce the risk of type 2 diabetes by 10%. It also finds that well controlled blood glucose can cut down various other risks of renal disease and cardiovascular risks by 21% and 30% respectively. The study has covered a long period of five years and involved around 11,000 people in various countries.
Talia Greek’s golden retriever puppy is more than just her best friend - she can potentially save her young owner from life-threatening hypoglycemic seizures.